MCD
47
-2
NEM
61
-2
DVA
61
2
AN
47
4
PAYX
56
3
IFF
48
3
DNB
66
-2
PG
58
3
VIX
52
-3
GRMN
49
3
CINF
50
5
MUR
31
2
FIS
90
12
KEY
50
3
FLR
45
2
MKC
59
5
DOV
55
3
HPE
50
-2
FRT
53
-2
MSI
60
3
MCD
47
-2
NEM
61
-2
DVA
61
2
AN
47
4
PAYX
56
3
IFF
48
3
DNB
66
-2
PG
58
3
VIX
52
-3
GRMN
49
3
CINF
50
5
MUR
31
2
FIS
90
12
KEY
50
3
FLR
45
2
MKC
59
5
DOV
55
3
HPE
50
-2
FRT
53
-2
MSI
60
3
Financhill
Back

Bristol-Myers Squibb 10K Form

Sell
46

BMY
Bristol-Myers Squibb

Last Price:
$49.21
Seasonality Move:
2.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $48.3B
Cash Flow: $1.7B
Price / Cash Flow: 7.64
Annual Sales: $8.54
Price / Book: 5.76

Profitability

EPS (TTM): 2.67000
Net Income (TTM): $5.4B
Gross Margin: $34.3B
Return on Equity: 32.01%
Return on Assets: 5.74%

Bristol-Myers Squibb Earnings Forecast

Key Bristol-Myers Squibb Financial Ratios

  • The Gross Profit Margin over the past 38 years for BMY is 71.08%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 17.42% of Gross Profit Margin.
  • The Research & Development expenses have been 23.10% of Revenue.
  • The Net Earning history of BMY is -18.53% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 19 years.

Bristol-Myers Squibb Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 2.86
Current Ratio: 1.28
Quick Ratio: 1.1

Price-to-Earnings

Trailing P/E Ratio: 14.88
Forward P/E Ratio: 8.1

BMY Technical Analysis vs Fundamental Analysis

Sell
46
Bristol-Myers Squibb (BMY) is a Sell

Is Bristol-Myers Squibb a Buy or a Sell?